files/journal/2022-09-02_14-28-25-000000_896.png

Journal of Food Technology

ISSN: Online 1993-6036
ISSN: Print 1684-8462
About US
Editors
Issues
Pages
Indexed in

Journal of Food Technology, Volume 20, Issue 3 (2022)

Journal of Food Technology (JFT) is open access peer reviewed official publication of MAK Hill Publications

References

  1. Actor, J., S.A. Hwang and M. Kruzel, 2009. Lactoferrin as a natural immune modulator. Curr. Pharm. Des., 15: 1956-1973.
  2. Chen, G.Y. and G. Nuñez, 2010. Sterile inflammation: Sensing and reacting to damage. Nat. Rev. Immunol., 10: 826-837.
  3. Ahmad, I., M. Owais, M. Shahid and F. Aqil, 2010. Combating Fungal Infections. 1st Edn., Springer Berlin Heidelberg, Berlin, Heidelberg, ISBN-27: 9783642121722,9783642121739, Pages: 539.
  4. Zimecki, M., R. Miedzybrodzki, J. Mazurier and G. Spik, 1999. Regulatory effects of lactoferrin and lipopolysaccharide on LFA-1 expression on human peripheral blood mononuclear cell. Arch. Immunol. Ther. Exp. (Warsz), 47: 257-264.
  5. Zimecki, M., 2002. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology, 205: 120-131.
  6. Zimecki, M., J. Mazurier, G. Spik and J.A. Kapp, 1995. Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology, 86: 122-127.
  7. Zimecki, M., J. Mazurier, M. Machnicki, Z. Wieczorek, J. Montreuil and G. Spik, 1991. Immunostimulatory activity of lactotransferrin and maturation of CD4− CD8− murine thymocytes. Immunol. Lett., 30: 119-123.
  8. Lönnerdal, B. and S. Iyer, 1995. Lactoferrin: Molecular structure and biological function. Annu. Rev. Nutr., 15: 93-110.
  9. Sanchez, L., M. Calvo and J.H. Brock, 1992. Biological role of lactoferrin.. Arch. Dis. Childhood, 67: 657-661.
  10. Clare, D., G. Catignani and H. Swaisgood, 2003. Biodefense properties of milk: The role of antimicrobial proteins and peptides. Curr. Pharm. Des., 9: 1239-1255.
  11. Baveye, S., E. Elass, J. Mazurier, G. Spik and D. Legrand, 1999. Lactoferrin: A multifunctional glycoprotein involved in the modulation of the inflammatory process. cclm, 37: 281-286.
  12. Baynes, R.D. and W.R. Bezwoda, 1994. Lactoferrin and the Inflammatory Response. In: Lactoferrin., Hutchens, T.W., S.V. Rumball and B. Lönnerdal, (Eds.)., Springer US, Boston, MA, ISBN-27: 9780306447341,9781461525486, pp: 133-141.
  13. Kruzel, M.L., Y. Harari, D. Mailman, J.K. Actor and M. Zimecki, 2002. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin. Exp. Immunol., 130: 25-31.
  14. Cox, T.M., J. Mazurier, G. Spik, J. Montreul and T.J. Peters, 1979. Iron binding proteins and influx of irom across the duodenal brush border. Biochim. Biophys. Acta (BBA) Gen. Subjects, 588: 120-128.
  15. Lopez, V., Y.A. Suzuki and B. Lönnerdal, 2006. Ontogenic changes in lactoferrin receptor and DMT1 in mouse small intestine: Implications for iron absorption during early life. Biochem. Cell Biol., 84: 337-344.
  16. Nielsen, S.M., G.H. Hansen and E.M. Danielsen, 2010. Lactoferrin targets t cells in the small intestine. J. Gastroenterol., 45: 1121-1128.
  17. Leveugle, B., J. Mazurier, D. Legrand, C. Mazurier, J. Montreuil and G. Spik, 1993. Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. Eur. J. Biochem., 213: 1205-1211.
  18. Degryse, B., J.G. Neels, R.P. Czekay, K. Aertgeerts, Y.I. Kamikubo and D.J. Loskutoff, 2004. The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. J. Bio. Chem., 279: 22595-22604.
  19. Mazurier, J., D. Legrand, W. Hu, J. Montreuil and G. Spik, 1989. Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Eur. J. Biochem., 179: 481-487.
  20. Birgens, H.S., N.E. Hansen, H. Karle and L.Ø. Kristensen, 1983. Receptor binding of lactoferrin by human monocytes. Br. J. Haematol., 54: 383-391.
  21. Bennett, R.M. and J. Davis, 1981. Lactoferrin binding to human peripheral blood cells: An interaction with a B-enriched population of lymphocytes and a subpopulation of adherent mononuclear cells. J. Immunol., 127: 1211-1216.
  22. van Snick, J.L., B. Markowetz and P.L. Masson, 1977. The ingestion and digestion of human lactoferrin by mouse peritoneal macrophages and the transfer of its iron into ferritin.. J. Exp. Med., 146: 817-827.
  23. McAbee, D.D., W. Nowatzke, C. Oehler, M. Sitaram and E. Sbaschnig et al., 1993. Endocytosis and degradation of bovine apo- and holo-lactoferrin by isolated rat hepatocytes are mediated by recycling calcium-dependent binding sites. Biochemistry, 32: 13749-13760.
  24. Lopez, V., S.L. Kelleher and B. Lönnerdal, 2008. Lactoferrin receptor mediates apo- but not holo-lactoferrin internalization via clathrin-mediated endocytosis in trophoblasts. Biochem. J., 411: 271-278.
  25. Huang, R.Q., W.L. Ke, Y.H. Qu, J.H. Zhu, Y.Y. Pei and C. Jiang, 2006. Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain. J. Biomed. Sci., 14: 121-128.
  26. Legrand, D., E. Elass, M. Carpentier and J. Mazurier, 2006. Interactions of lactoferrin with cells involved in immune function. Biochem. Cell Biol., 84: 282-290.
  27. Roşeanu, A., F. Chelu, M. Trif, C. Motaş and J.H. Brock, 2000. Inhibition of binding of lactoferrin to the human promonocyte cell line THP-1 by heparin: The role of cell surface sulphated molecules. Biochim. Biophys. Acta (BBA) Gen. Subjects, 1475: 35-38.
  28. Suzuki, Y.A., V. Lopez and B. Lönnerdal, 2005. Mammalian lactoferrin receptors: Structure and function. Cell. Mol. Life Sci., 62: 2560-2575.
  29. Mincheva‐Nilsson, L., S. Hammarström and M.L. Hammarström, 1997. Activated human γδ T lymphocytes express functional lactoferrin receptors. Scand. J. Immunol., 46: 609-618.
  30. Hammarström, M.L., L. Mincheva-Nilsson and S. Hammarström, 1995. Functional Lactoferrin Receptors on Activated Human Lymphocytes. In: Advances in Mucosal Immunology., Mestecky, J., M.W. Russell, S. Jackson, S.M. Michalek, H. Tlaskalová-Hogenová and J. Šterzl, (Eds.)., Springer US, Boston, MA, ISBN-27: 9781461357964,9781461519416, pp: 47-53.
  31. Birgens, H.S., 1994. The Monocytic Receptor for Lactoferrin and its Involvement in Lactoferrin-Mediated Iron Transport. In: Lactoferrin., Hutchens, T.W., S.V. Rumball and B. Lönnerdal, (Eds.)., Springer US, Boston, MA, ISBN-27: 9780306447341,9781461525486, pp: 99-109.
  32. Iyer, S. and B. Lönnerdal, 1993. Lactoferrin, lactoferrin receptors and iron metabolism. Eur. J. Clin. Nutr., 47: 232-241.
  33. Groot, F., T.B.H. Geijtenbeek, R.W. Sanders, C.E. Baldwin and M. Sanchez-Hernandez et al., 2005. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN—gp120 interaction. J. Virol., 79: 3009-3015.
  34. Damiens, E., J. Mazurier, I.E. Yazidi, M. Masson, I. Duthille, G. Spik and Y. Boilly-Marer, 1998. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim. Biophys. Acta 1402: 277-287.
  35. Shau, H., A. Kim and S.H. Golub, 1992. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J. Leukocyte Biol., 51: 343-349.
  36. Miyauchi, H., S.I. Hashimoto, M. Nakajima, I. Shinoda, Y. Fukuwatari and H. Hayasawa, 1998. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: Identification of its active domain. Cell. Immunol., 187: 34-37.
  37. Kawai, K., K. Shimazaki, H. Higuchi and H. Nagahata, 2007. Antibacterial activity of bovine lactoferrin hydrolysate against mastitis pathogens and its effect on superoxide production of bovine neutrophils. Zoonoses Public Health, 54: 160-164.
  38. Ward, P.P., M. Mendoza-Meneses, P.W. Park and O.M. Conneely, 2008. Stimulus-dependent impairment of the neutrophil oxidative burst response in lactoferrin-deficient mice. Am. J. Pathol., 172: 1019-1029.
  39. Longhi, C., M.P. Conte, M. Penta, A. Cossu, G. Antonini, F. Superti and L. Seganti, 2004. Lactoferricin influences early events of Listeria monocytogenes infection in THP-1 human macrophages. J. Med. Microbiol., 53: 87-91.
  40. Wakabayashi, H., N. Takakura, S. Teraguchi and Y. Tamura, 2003. Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans. Microbiol. Immunol., 47: 37-43.
  41. Sorimachi, K., K. Akimoto, Y. Hattori, T. Ieiri and A. Niwa, 1997. Activation of macrophages by lactoferrin: Secretion of TNF-α, IL-8 and NO. IUBMB Life, 43: 79-87.
  42. Na, Y.J., S.B. Han, J.S. Kang, Y.D. Yoon and S.K. Park et al., 2004. Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. Int. Immunopharmacol., 4: 1187-1199.
  43. Puddu, P., M.G. Carollo, F. Belardelli, P. Valenti and S. Gessani, 2007. Role of endogenous interferon and lps in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages. J. Leukocyte Biol., 82: 347-353.
  44. Actor, J.K., S.A. Hwang, M. Olsen, M. Zimecki, R.L. Hunter and M.L. Kruzel, 2002. Lactoferrin immunomodulation of DTH response in mice. Int. Immunopharmacology, 2: 475-486.
  45. Zimecki, M., A. Właszczyk, R. Wojciechowski, J. Dawiskiba and M. Kruzel, 2001. Lactoferrin regulates the immune responses in post-surgical patients. Arch. Immunol. Ther. Exp. (Warsz)., 49: 325-333.
  46. Machnicki, M., M. Zimecki and T. Zagulski, 1993. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 In vivo. Int. J. Exp. Pathol., 74: 433-439.
  47. Håversen, L., B.G. Ohlsson, M. Hahn-Zoric, L.Å. Hanson and I. Mattsby-Baltzer, 2002. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB. Cell. Immunol., 220: 83-95.
  48. Zimecki, M., K. Spiegel, A. Właszczyk, A. Kübler and M.L. Kruzel, 1999. Lactoferrin increases the output of neutrophil precursors and attenuates the spontaneous production of TNF-alpha and IL-6 by peripheral blood cells. Arch. Immunol. Ther. Exp. (Warsz), 47: 113-118.
  49. Wakabayashi, H., M. Kurokawa, K. Shin, S. Teraguchi, Y. Tamura and K. Shiraki, 2004. Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice. Biosci., Biotechnol., Biochem., 68: 537-544.
  50. Wakabayashi, H., N. Takakura, K. Yamauchi and Y. Tamura, 2006. Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin. Clin. Vaccine Immunol., 13: 239-245.
  51. Teraguchi, S., H. Wakabayashi, H. Kuwata, K. Yamauchi and Y. Tamura, 2004. Protection against infections by oral lactoferrin: Evaluation in animal models. BioMetals, 17: 231-234.
  52. Hwang, S.A., K.M. Wilk, Y.A. Bangale, M.L. Kruzel and J.K. Actor, 2007. Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Med. Microbiol. Immunol., 196: 171-180.
  53. Wilk, K.M., S.A. Hwang and J.K. Actor, 2007. Lactoferrin modulation of antigen-presenting-cell response to BCG infection. Postepy, Hig. Med. Dosw., 61: 277-282.
  54. Trinchieri, G., 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol., 3: 133-146.
  55. Puddu, P., P. Valenti and S. Gessani, 2009. Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie, 91: 11-18.
  56. Latorre, D., P. Puddu, P. Valenti and S. Gessani, 2010. Reciprocal interactions between lactoferrin and bacterial endotoxins and their role in the regulation of the immune response. Toxins, 2: 54-68.
  57. Zimecki, M. and M. Machnicki, 1994. Lactoferrin inhibits the effector phase of the delayed type hypersensitivity to sheep erythrocytes and inflammatory reactions to M. bovis (BCG). Arch. Immunol. Ther. Exp., 42: 171-177.
  58. Baker, E.N. and H.M. Baker, 2005. Lactoferrin. Cell. Mol. Life Sci., 62: 2531-2539.
  59. Schmitt, E., P. Hoehn, C. Huels, S. Goedert, N. Palm, E. Rüde and T. Germann, 1994. T helper type 1 development of naive CD4+T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol., 24: 793-798.
  60. Gately, M.K., L.M. Renzetti, J. Magram, A.S. Stern, L. Adorini, U. Gubler and D.H. Presky, 1998. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses. Annual Rev. Immunol., 16: 495-521.
  61. Murphy, K.M. and S.L. Reiner, 2002. The lineage decisions of helper T cells. Nat. Rev. Immunol., 2: 933-944.
  62. Ahmadzadeh, M. and D.L. Farber, 2002. Functional plasticity of an antigen-specific memory CD4 t cell population. Proc. Nat. Acad. Sci., 99: 11802-11807.
  63. Radhakrishnan, S., K.R. Wiehagen, V. Pulko, V.V. Keulen, W.A. Faubion, K.L. Knutson and L.R. Pease, 2007. Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-gamma. The J. Immunol., 178: 3583-3592.
  64. Saidi, H., J. Eslaphazir, C. Carbonneil, L. Carthagena, M. Requena, N. Nassreddine and L. Belec, 2006. Differential modulation of human lactoferrin activity against both R5 and X4-HIV-1 adsorption on epithelial cells and dendritic cells by natural antibodies. The J. Immunol., 177: 5540-5549.
  65. Toebak, M.J., J. de Rooij, H. Moed, T.J. Stoof and B.M.E. von Blomberg et al., 2007. Differential suppression of dendritic cell cytokine production by anti-inflammatory drugs. Br. J. Dermatol., 158: 225-233.
  66. Spadaro, M., C. Caorsi, P. Ceruti, A. Varadhachary, G. Forni, F. Pericle and M. Giovarelli, 2008. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. The FASEB J., 22: 2747-2757.
  67. Tanaka, T., H. Morita, Y.C. Yoo, W.S. Kim, H. Kumura and K.I. Shimazaki, 2004. Detection of bovine lactoferrin binding protein on jurkat human lymphoblastic T cell line. J. Vet. Med. Sci., 66: 865-869.
  68. Legrand, D., P.H.C.V. Berkel, V. Salmon, A.H.V. Veen, M.C. Slomianny, H.J. Nuijens and G. Spik, 1997. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. Biochem. J., 327: 841-846.
  69. Bi, B.Y., J.L. Liu, D. Legrand, A.C. Roche, M. Capron, G. Spik and J. Mazurier, 1996. Internalization of human lactoferrin by the Jurkat human lymphoblastic T-cell line. Eur. J. Cell Biol., 69: 288-296.
  70. Dhennin-Duthille, I., M. Masson, E. Damiens, C. Fillebeen, G. Spik and J. Mazurier, 2000. Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T jurkat cell line. J. Cell. Biochem., 79: 583-593.
  71. Frydecka, I., M. Zimecki, D. Bocko, A. Kosmaczewska and R. Teodorowska, 2002. Lactoferrin-induced up-regulation of zeta (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients. Anticancer Res., 22: 1897-1901.
  72. Zimecki, M., D. Stepniak, A. Szynol and M.L. Kruzel, 2001. Lactoferrin regulates proliferative response of human peripheral blood mononuclear cells to phytohemagglutinin and mixed lymphocyte reaction. Arch. Immunologiae, Ther. Exp., 12: 53-114.
  73. Kobayashi, S., R. Sato, O. Inanami, T. Yamamori and O. Yamato et al., 2005. Reduction of concanavalin a-induced expression of interferon-γ by bovine lactoferrin in feline peripheral blood mononuclear cells. Vet. Immunol. Immunopathol., 105: 75-84.
  74. Moed, H., T.J. Stoof, D.M. Boorsma, B.M.E. von Blomberg and S. Gibbs et al., 2004. Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles. Clin. Exp. Allergy, 34: 1868-1875.
  75. Kocieba M., M. Zimecki, M. Kruzel and J. Actor, 2002. The adjuvant activity of lactoferrin in the generation of DTH to ovalbumin can be inhibited by bovine serum albumin bearing alpha-D-mannopyranosyl residues. Cell. Mol. Biol. Lett., 7: 1131-1136.
  76. Zimecki, M. and M.L. Kruzel, 2000. Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice. Immunol. Lett., 74: 183-188.
  77. Artym, J., M. Zimecki and M.L. Kruzel, 2003. Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment. Immunobiology, 207: 197-205.
  78. Artym, J., M. Zimecki, M. Paprocka and M.L. Kruzel, 2003. Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunol. Lett., 89: 9-15.
  79. Hara, K., 2002. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatology Res., 24: 228-235.
  80. Saltanat, H., H. Li, Y. Xu, J. Wang, F. Liu and X.H. Geng, 2009. The influences of camel milk on the immune response of chronic hepatitis B patients. Chinese J. Cell. Mol. Immunol., 25: 431-433.
  81. Sfeir, R.M., M. Dubarry, P.N. Boyaka, M. Rautureau and D. Tomé, 2004. The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice. The J. Nutr., 134: 403-409.
  82. Debbabi, H., M. Dubarry, M. Rautureau and D. Tomé, 1998. Bovine lactoferrin induces both mucosal and systemic immune response in mice. J. Dairy Res., 65: 283-293.
  83. Choi, B.K., J.K. Actor, S. Rios, M. d’Anjou and T.A. Stadheim et al., 2008. Recombinant human lactoferrin expressed in glycoengineered pichia pastoris: Effect of terminal n-acetylneuraminic acid on in vitro secondary humoral immune response. Glycoconjugate J., 25: 581-593.
  84. Spik, G., B. Coddeville, J. Mazurier, Y. Bourne, C. Cambillaut and J. Montreuil, 1994. Primary and Three-Dimensional Structure of Lactotransferrin (Lactoferrin) Glycans. In: Lactoferrin, Hutchens, T.W., S.V. Rumball and B. Lönnerdal, (Eds.)., Springer US, Boston, MA, ISBN-27: 9780306447341,9781461525486, pp: 21-32.
  85. Konuspayeva, G., B. Faye, G. Loiseau and D. Levieux, 2007. Lactoferrin and immunoglobulin contents in camel's milk (Camelus bactrianus, Camelus dromedarius, and hybrids) from Kazakhstan. J. Dairy Sci., 90: 38-46.
  86. Breton-Gorius, J., D.Y. Mason, D. Buriot, J.L. Vilde and C. Griscelli, 1980. Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Am. J. Pathol., 99: 413-428.
  87. Kruzel, M.L., A. Bacsi, B. Choudhury, S. Sur and I. Boldogh, 2006. Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology, 119: 159-166.
  88. Kane, S.V., W.J. Sandborn, P.A. Rufo, A. Zholudev and J. Boone et al., 2003. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am. J. Gastroenterol., 98: 1309-1314.
  89. Zimecki, M., J. Dawiskiba, B. Zawirska, Z. Krawczyk and M. Kruzel, 2003. Bovine lactoferrin decreases histopathological changes in the liver and regulates cytokine production by splenocytes of obstructive jaundiced rats. Inflammation Res., 52: 305-310.
  90. Togawa, J.I., H. Nagase, K. Tanaka, M. Inamori and A. Nakajima et al., 2002. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J. Gastroenterol. Hepatol., 17: 1291-1298.
  91. Arab, H.H., S.A. Salama, T.M. Abdelghany, H.A. Omar, E.S.A. Arafa, M.M. Alrobaian and I.A. Maghrabi, 2017. Camel milk attenuates rheumatoid arthritis via inhibition of mitogen activated protein kinase pathway. Cell. Physiol. Biochem., 43: 540-552.
  92. Appelmelk, B.J., Y.Q. An, M. Geerts, B.G. Thijs and H.A. de Boer et al., 1994. Lactoferrin is a lipid a-binding protein. Infec. Immun.., 62: 2628-2632.
  93. Brandenburg, K., G. Jürgens, M. Müller, S. Fukuoka and M.H.J. Koch, 2001. Biophysical characterization of lipopolysaccharide and lipid a inactivation by lactoferrin. Bio. Chem., 382: 1215-1225.
  94. Elass-Rochard, E., A. Roseanu, D. Legrand, M. Trif and V. Salmon et al., 1995. Lactoferrin-lipopolysaccharide interaction: Involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J., 312: 839-845.
  95. Mattsby-Baltzer, I., A. Roseanu, C. Motas, J. Elverfors, I. Engberg and L.Å. Hanson, 1996. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res., 40: 257-262.
  96. Zhang, G.H., D.M. Mann and C.M. Tsai, 1999. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infec. Immun.., 67: 1353-1358.
  97. Elass-Rochard, E., D. Legrand, V. Salmon, A. Roseanu and M. Trif et al., 1998. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infec. Immun.., 66: 486-491.
  98. Baveye, S., E. Elass, J. Mazurier and D. Legrand, 2000. Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils. FEBS Lett., 469: 5-8.
  99. Britigan, B.E., T.S. Lewis, M. Waldschmidt, M.L. McCormick and A.M. Krieg, 2001. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. The J. Immunol., 167: 2921-2928.
  100. Mulligan, P., N.R.J. White, G. Monteleone, P. Wang, J.W. Wilson, Y. Ohtsuka and I.R. Sanderson, 2006. Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells. Pediatr. Res., 59: 656-661.
  101. Hayashida, K.I., T. Kaneko, T. Takeuchi, H. Shimizu, K. Ando and E. Harada, 2004. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J. Vet. Med. Sci., 66: 149-154.
  102. Sasaki, Y., K. Otsuki, A. Hasegawa, M. Sawada and H. Chiba et al., 2004. Preventive effect of recombinant human lactoferrin on lipopolysaccharide-induced preterm delivery in mice. Acta Obstetricia Gynecologica Scand., 83: 1035-1038.
  103. Ouadoud, M., M.Y. Chkouri and A. Nejjari, 2018. Leadertice: A platforms recommendation system based on a comparative and evaluative study of free e-learning platforms. Int. J. Online Biomed. Eng. (iJOE), 14: 132-161.
  104. Curran, C.S., K.P. Demick and J.M. Mansfield, 2006. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell. Immunol., 242: 23-30.
  105. Iigo, M., M. Shimamura, E. Matsuda, K.I. Fujita and H. Nomoto et al., 2004. Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: A possible explanation for inhibition of carcinogenesis and metastasis. Cytokine, 25: 36-44.
  106. Shimamura, M., Y. Yamamoto, H. Ashino, T. Oikawa, T. Hazato, H. Tsuda and M. Iigo, 2004. Bovine lactoferrin inhibits tumor-induced angiogenesis. Int. J. Cancer, 111: 111-116.
  107. Ishii, K., 2003. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol. Res., 25: 226-233.
  108. Takakura, N., H. Wakabayashi, H. Ishibashi, K. Yamauchi and S. Teraguchi et al., 2004. Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J. Med. Microbiol., 53: 495-500.
  109. Caccavo, D., G.D. Sebastiani, C.D. Monaco, F. Guido and M. Galeazzi et al., 1999. Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis. Int. J. Clin. Lab. Res., 29: 30-35.
  110. Reghunathan, R., M. Jayapal, L.Y. Hsu, H.H. Chng, D. Tai, B.P. Leung and A.J. Melendez, 2005. Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunol., Vol. 6. 10.1186/1471-2172-6-2.
  111. Greenberg, D.E., Z. Jiang, R. Steffen, M.P. Verenker and H.L. DuPont, 2002. Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. The J. Infect. Dis., 185: 944-949.
  112. Qadri, F., M.S. Alam, M. Nishibuchi, T. Rahman and N.H. Alam et al., 2003. Adaptive and inflammatory immune responses in patients infected with strains of Vibrio parahaemolyticus. The J. Infect. Dis., 187: 1085-1096.
  113. Judd, T.A., A.S. Day, D.A. Lemberg, D. Turner and S.T. Leach, 2011. Update of fecal markers of inflammation in inflammatory bowel disease. J. Gastroenterol. Hepatology, 26: 1493-1499.
  114. Al-Majali, A.M., Z.B. Ismail, Y. Al-Hami and A.Y. Nour, 2007. Lactoferrin concentration in milk from camels (Camelus dromedarius) with and without subclinical mastitis. Int. J. Appl. Res. Vet. Med., 5: 120-124.
  115. Kruzel, M.L., J.K. Actor, M. Zimecki, J. Wise and P. Płoszaj et al., 2013. Novel recombinant human lactoferrin: Differential activation of oxidative stress related gene expression. J. Biotechnol., 168: 666-675.
  116. Marnett, L.J., 2000. Oxyradicals and DNA damage. Carcinogenesis, 21: 361-370.
  117. Ruef, J., K. Peter, T.K. Nordt, M.S. Runge, W. Kübler and C. Bode, 1999. Oxidative stress and atherosclerosis: Its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb. Haemost., 82: 32-37.
  118. Poli, G. and J. Schaur, 2001. 4-hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life, 50: 315-321.
  119. Okazaki, Y., I. Kono, T. Kuriki, S. Funahashi and S. Fushimi et al., 2012. Bovine lactoferrin ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats. J. Clin. Biochem. Nutr., 51: 84-90.
  120. Kruzel, M.L., J.K. Actor, Z. Radak, A. Bacsi, A. Saavedra-Molina and I. Boldogh, 2009. Lactoferrin decreases lps-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. Innate Immun.., 16: 67-79.
  121. Konishi, M., M. Iwasa, K. Yamauchi, R. Sugimoto and N. Fujita et al., 2006. Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C. Hepatol. Res., 36: 27-32.
  122. Al-Hashem, F., M. Dallak, N. Bashir, M. Abbas, R. Elessa, M. Khalil and M. Al-Khateeb, 2009. Camel's milk protects against cadmium chloride induced toxicity in white albino rats. Am. J. Pharmacol. Toxicol., 4: 107-117.
  123. Elrod, K.C., W.R. Moore, W.M. Abraham and R.D. Tanaka, 1997. Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep. Am. J. Respir. Crit. Care Med., 156: 375-381.
  124. Griffiths, C.E.M., M. Cumberbatch, S.C. Tucker, R.J. Dearman, S. Andrew, D.R. Headon and I. Kimber, 2001. Exogenous topical lactoferrin inhibits allergen-induced langerhans cell migration and cutaneous inflammation in humans. Br. J. Dermatol., 144: 715-725.
  125. Zweiman, B., U. Kucich, M. Shalit, C.V. Allmen, A. Moskovitz, G. Weinbaum and P.C. Atkins, 1990. Release of lactoferrin and elastase in human allergic skin reactions. J. Immunol., 144: 3953-3960.
  126. Cumberbatch, M., M. bhushan, R.J. Dearman, I. Kimber and C.E.M. Griffiths, 2003. Il-1β-induced langerhans’ cell migration and TNF-α production in human skin: Regulation by lactoferrin. Clin. Exp. Immunol., 132: 352-359.
  127. Kimber, I., M. Cumberbatch, R.J. Dearman, D.R. Headon, M. Bhushan and C.E. Griffiths, 2002. Lactoferrin: Influences on langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem. Cell Biol., 80: 103-107.
  128. He, S., A.R. McEuen, S.A. Blewett, P. Li, M.G. Buckley, P. Leufkens and A.F. Walls, 2003. The inhibition of mast cell activation by neutrophil lactoferrin: Uptake by mast cells and interaction with tryptase, chymase and cathepsin G. Biochem. Pharmacol., 65: 1007-1015.